S16961

CAS No. 153874-14-7

S16961( S169611 )

Catalog No. M26429 CAS No. 153874-14-7

S16961 is an agonist of nicotinic receptor.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 67 In Stock
5MG 117 In Stock
10MG 186 In Stock
25MG 373 In Stock
50MG 537 In Stock
100MG 762 In Stock
200MG 1004 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    S16961
  • Note
    Research use only, not for human use.
  • Brief Description
    S16961 is an agonist of nicotinic receptor.
  • Description
    S16961 is an agonist of nicotinic receptor.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    S169611
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    153874-14-7
  • Formula Weight
    674.02
  • Molecular Formula
    C41H71NO6
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)c1cccnc1)OC(=O)CCCCCCCCCCCCCCC
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Synthesis of Substituted β‐Functionalised Styrenes by Microwave‐Assisted Olefin
molnova catalog
related products
  • Benzoylaconitine

    Benzoylaconine is an alkaloid in the Chinese traditional medicine Radix Aconiti Lateralis Preparata (Fuzi). Benzoylaconine and aconitine can induce reproductive toxicity in BeWo Cell the amino acid metabolism was the main metabolic pathway and responsible for the placental and fetal toxicity of them.

  • Brandioside

    Brandioside shows strong antioxidant, and neuroprotective effects, it significantly attenuates glutamate-induced neurotoxicity at concentrations ranging from 0.1 to 10 microM; it exhibits significant inhibition of advanced glycation end product formation with the IC50 value of 4.6-25.7 μM.

  • 12(S)-HETE

    12(S)-HETE is the predominant lipoxygenase product of mammalian platelets. It enhances tumor cell adhesion to endothelial cells, fibronectin, and the subendothelial matrix at 0.1μM181M.